EX-10.14 18 d513724dex1014.htm EX-10.14 EXECUTION VERSION CONFIDENTIAL SETTLEMENT AND TERMINATION AGREEMENTSettlement and Termination Agreement • May 5th, 2020 • Delaware
Contract Type FiledMay 5th, 2020 JurisdictionTHIS SETTLEMENT AND TERMINATION AGREEMENT (“Termination Agreement”) dated as of October 8, 2012 (“Execution Date”), is entered into between Revance Therapeutics, Inc., a Delaware corporation having its principal place of business at 7555 Gateway Blvd., Newark, CA 94560 (“Revance”) and Medicis Pharmaceutical Corporation, a Delaware corporation with offices at 7720 North Dobson Road, Scottsdale, AZ 85256 (“Medicis”).
SETTLEMENT AND TERMINATION AGREEMENTSettlement and Termination Agreement • June 4th, 2013 • Revance Therapeutics, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledJune 4th, 2013 Company Industry JurisdictionTHIS SETTLEMENT AND TERMINATION AGREEMENT (“Termination Agreement”) dated as of October 8, 2012 (“Execution Date”), is entered into between Revance Therapeutics, Inc., a Delaware corporation having its principal place of business at 7555 Gateway Blvd., Newark, CA 94560 (“Revance”) and Medicis Pharmaceutical Corporation, a Delaware corporation with offices at 7720 North Dobson Road, Scottsdale, AZ 85256 (“Medicis”).